Drug Pricing
Business & Economics
The Bizarre World of Drug Pricing
There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
Wayne Winegarden
November 19, 2018
Drug Pricing
Sally Pipes Talks ‘Reinsurance’ Obamacare Fix in Washington Times
‘Reinsurance’ Obamacare fix wins bipartisan support in Senate By Tom Howell, Jr. Sen. Joe Manchin III, a West Virginia Democrat who just won re-election in one of the country’s reddest states, has an idea to fix Obamacare — call in President Trump. The West Virginian is among senators on both ...
Pacific Research Institute
November 14, 2018
Commentary
Putting Drug Prices on TV Will Cause Unnecessary Patient Panic
Last month, the Trump administration proposed several reforms to drive down prescription drug prices. One measure would force pharmaceutical companies to mention the sticker prices of their medicines in television advertisements. The new mandate covers all prescriptions drugs reimbursed by Medicare or Medicaid that cost more than $35 a month. The administration hopes this ...
Sally C. Pipes
November 9, 2018
Business & Economics
Wayne Winegarden Talks Drug Pricing Transparency on Lars Larson Show
Listen to PRI’s senior fellow in business and economics Dr. Wayne Winegarden discuss President Trump’s drug pricing transparency proposal on the nationally-syndicated “Lars Larson Show.” The interview begins at the 54:25 mark.
Pacific Research Institute
October 31, 2018
Blog
Does President Trump Favor Price Controls?
At 2 pm Eastern time today, President Trump spoke at the Department of Health and Human Services where he recommended a litany of policies that would ultimately impose price controls on the pharmaceutical market. Take his proposal to force the prices paid by Medicare for drugs administer in doctors’ offices ...
Wayne Winegarden
October 25, 2018
Commentary
Drug prices in ads actually hurt consumers
This month, the Trump administration proposed a new rule that would require advertisements for prescription drugs covered by Medicare or Medicaid to include the list price of the medicine. To be sure, a free market is dependent on consumers making informed decisions. But this move would provide patients with incomplete, misleading numbers ...
Sally C. Pipes
October 23, 2018
Business & Economics
Wayne Winegarden Talks Drug Pricing Advertising on Newsmax TV
Watch PRI’s Wayne Winegarden discuss the Trump Administration proposal on drug pricing advertising on “America Talks Live” with Dr. Gina Loudon and John Cardillo on Newsmax TV.
Newsmax TV
October 17, 2018
Commentary
Where’s the Outrage?
How can you tell if competition is working in a given market? Generally speaking, prices go down while quality goes up. Productivity increases as more efficient methods are discovered. Shortages are rare to nonexistent. And, most important, consumers win. Government intervention, monopolies, and other market distortions can disrupt the normal ...
Sally C. Pipes
September 4, 2018
Commentary
Why Health-Care Mergers Aren’t So Scary
Prominent politicos are voicing concerns about the wave of impending mergers in the health-care industry. On August 1, California insurance commissioner Dave Jones urged the Justice Department to block the merger of Aetna and CVS, fretting it “will have anticompetitive effects and … harm consumers.” Days later, the American Medical Association echoed his concerns. ...
Sally C. Pipes
August 30, 2018
Commentary
Single-Payer Progressives Lie Their Way to Victory
November’s midterm elections are just around the corner. This fall, Democratic congressional candidates are betting the farm — or shall we say the House — on government-run health care. The crop of Democrats eyeing the presidency in 2020, meanwhile, is similarly united behind a government takeover of the U.S. healthcare ...
Sally C. Pipes
August 20, 2018
The Bizarre World of Drug Pricing
There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
Sally Pipes Talks ‘Reinsurance’ Obamacare Fix in Washington Times
‘Reinsurance’ Obamacare fix wins bipartisan support in Senate By Tom Howell, Jr. Sen. Joe Manchin III, a West Virginia Democrat who just won re-election in one of the country’s reddest states, has an idea to fix Obamacare — call in President Trump. The West Virginian is among senators on both ...
Putting Drug Prices on TV Will Cause Unnecessary Patient Panic
Last month, the Trump administration proposed several reforms to drive down prescription drug prices. One measure would force pharmaceutical companies to mention the sticker prices of their medicines in television advertisements. The new mandate covers all prescriptions drugs reimbursed by Medicare or Medicaid that cost more than $35 a month. The administration hopes this ...
Wayne Winegarden Talks Drug Pricing Transparency on Lars Larson Show
Listen to PRI’s senior fellow in business and economics Dr. Wayne Winegarden discuss President Trump’s drug pricing transparency proposal on the nationally-syndicated “Lars Larson Show.” The interview begins at the 54:25 mark.
Does President Trump Favor Price Controls?
At 2 pm Eastern time today, President Trump spoke at the Department of Health and Human Services where he recommended a litany of policies that would ultimately impose price controls on the pharmaceutical market. Take his proposal to force the prices paid by Medicare for drugs administer in doctors’ offices ...
Drug prices in ads actually hurt consumers
This month, the Trump administration proposed a new rule that would require advertisements for prescription drugs covered by Medicare or Medicaid to include the list price of the medicine. To be sure, a free market is dependent on consumers making informed decisions. But this move would provide patients with incomplete, misleading numbers ...
Wayne Winegarden Talks Drug Pricing Advertising on Newsmax TV
Watch PRI’s Wayne Winegarden discuss the Trump Administration proposal on drug pricing advertising on “America Talks Live” with Dr. Gina Loudon and John Cardillo on Newsmax TV.
Where’s the Outrage?
How can you tell if competition is working in a given market? Generally speaking, prices go down while quality goes up. Productivity increases as more efficient methods are discovered. Shortages are rare to nonexistent. And, most important, consumers win. Government intervention, monopolies, and other market distortions can disrupt the normal ...
Why Health-Care Mergers Aren’t So Scary
Prominent politicos are voicing concerns about the wave of impending mergers in the health-care industry. On August 1, California insurance commissioner Dave Jones urged the Justice Department to block the merger of Aetna and CVS, fretting it “will have anticompetitive effects and … harm consumers.” Days later, the American Medical Association echoed his concerns. ...
Single-Payer Progressives Lie Their Way to Victory
November’s midterm elections are just around the corner. This fall, Democratic congressional candidates are betting the farm — or shall we say the House — on government-run health care. The crop of Democrats eyeing the presidency in 2020, meanwhile, is similarly united behind a government takeover of the U.S. healthcare ...